A new injectable to prevent and treat hypoglycemia (IMAGE)

American Chemical Society

A new injectable to prevent and treat hypoglycemia

Caption

Encapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the hormone into the bloodstream and triggering the liver to release glucose. At normal sugar levels (more than 100 mg/dL), the micelles remain intact, keeping glucagon inactive.

Credit

Adapted from ACS Central Science 2024, DOI: 10.1021/acscentsci.4c00937

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.